Petra Hegmann, Author at MC Services corporate website

-1

archive,author,author-petra-hegmann,author-9,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as “critical infrastructure” by the Federal Chancellery

AiCuris gets involved in the fight against Corona

APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19

France Biotech: A new Patient-Centered Endowment Fund launched by France Biotech: “HealthTech For Care”

InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology

Newron AGM Result and Clinical and Business Update

Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD

Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy

Heidelberg Pharma AG: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal

Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway